Annual Accounts Payable
$6.17 M
+$4.94 M+402.95%
31 December 2023
Summary:
HCW Biologics annual accounts payable is currently $6.17 million, with the most recent change of +$4.94 million (+402.95%) on 31 December 2023. During the last 3 years, it has risen by +$6.01 million (+3871.15%). HCWB annual accounts payable is now at all-time high.HCWB Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$22.67 M
+$5.79 M+34.30%
30 September 2024
Summary:
HCW Biologics quarterly accounts payable is currently $22.67 million, with the most recent change of +$5.79 million (+34.30%) on 30 September 2024. Over the past year, it has increased by +$19.51 million (+618.69%). HCWB quarterly accounts payable is now at all-time high.HCWB Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HCWB Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +402.9% | +618.7% |
| 3 y3 years | +3871.2% | +3457.1% |
| 5 y5 years | - | - |
HCWB Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +3871.2% | at high | >+9999.0% |
| 5 y | 5 years | at high | +3871.2% | at high | >+9999.0% |
| alltime | all time | at high | +3871.2% | at high | >+9999.0% |
HCW Biologics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $22.67 M(+34.3%) |
| June 2024 | - | $16.88 M(+60.8%) |
| Mar 2024 | - | $10.49 M(+70.1%) |
| Dec 2023 | $6.17 M(+403.0%) | $6.17 M(+95.5%) |
| Sept 2023 | - | $3.15 M(+49.0%) |
| June 2023 | - | $2.12 M(+81.7%) |
| Mar 2023 | - | $1.16 M(-5.0%) |
| Dec 2022 | $1.23 M | $1.23 M(-13.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $1.41 M(+376.2%) |
| June 2022 | - | $296.20 K(-60.1%) |
| Mar 2022 | - | $743.10 K(+232.2%) |
| Dec 2021 | $223.70 K(+44.0%) | $223.70 K(-64.9%) |
| Sept 2021 | - | $637.20 K(-36.1%) |
| June 2021 | - | $996.90 K(+208.2%) |
| Mar 2021 | - | $323.50 K(+108.3%) |
| Dec 2020 | $155.30 K(-60.4%) | $155.30 K |
| Dec 2019 | $392.30 K | - |
FAQ
- What is HCW Biologics annual accounts payable?
- What is the all time high annual accounts payable for HCW Biologics?
- What is HCW Biologics annual accounts payable year-on-year change?
- What is HCW Biologics quarterly accounts payable?
- What is the all time high quarterly accounts payable for HCW Biologics?
- What is HCW Biologics quarterly accounts payable year-on-year change?
What is HCW Biologics annual accounts payable?
The current annual accounts payable of HCWB is $6.17 M
What is the all time high annual accounts payable for HCW Biologics?
HCW Biologics all-time high annual accounts payable is $6.17 M
What is HCW Biologics annual accounts payable year-on-year change?
Over the past year, HCWB annual accounts payable has changed by +$4.94 M (+402.95%)
What is HCW Biologics quarterly accounts payable?
The current quarterly accounts payable of HCWB is $22.67 M
What is the all time high quarterly accounts payable for HCW Biologics?
HCW Biologics all-time high quarterly accounts payable is $22.67 M
What is HCW Biologics quarterly accounts payable year-on-year change?
Over the past year, HCWB quarterly accounts payable has changed by +$19.51 M (+618.69%)